HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Firms Launch New Brands, But Charged With Same Violations By FTC

Executive Summary

Firms allegedly made false claims for four products labeled as supplements they launched since 2018 settlement. “Brazenly ignoring the Court’s order barring them from making unsubstantiated claims,” firms “have continued promoting their products with outrageous claims,” FTC contends.

You may also be interested in...



Supplement Firms Agree To Leave Market After Being Released From FTC Contempt Complaint

FTC announces Health Research Laboratories, Whole Body Supplements and their owner, Kramer Duhon, agree to settlement in administrative proceeding opened in November 2020 after federal judge dismissed contempt complaint from 2018 settlement.

FTC Targets Supplement Firm In Administrative Proceeding After Contempt Complaint Fails

A ruling in Maine federal court questions whether FTC could show firms made claims a product labeled as a supplement “cures, mitigates, or treats any disease." But agency's administrative complaint includes the same phrase as a stipulation among the penalties it would order.

FTC Curbs Another 'Free' Ride: Health And Wellness Industry News

Health Research Laboratories agrees to settle an FTC complaint alleging false "free" offers on top of bogus health claims; reports that biotin can interfere with certain lab tests are reminders for consumers to tell doctors about supplements they use, says CRN; kratom group asks FDA and states "to tone down their overheated rhetoric about the non-opiate botanical"; and health and wellness recalls.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel